| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1460-9568.1996.TB01258.X |
| P698 | PubMed publication ID | 9081624 |
| P50 | author | Anders Björklund | Q5577627 |
| P2093 | author name string | P A Hantzopoulos | |
| A Martinez-Serrano | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 727-735 | |
| P577 | publication date | 1996-04-01 | |
| P1433 | published in | European Journal of Neuroscience | Q5412733 |
| P1476 | title | Ex vivo gene transfer of brain-derived neurotrophic factor to the intact rat forebrain: neurotrophic effects on cholinergic neurons | |
| P478 | volume | 8 |
| Q48308896 | A transgenic mouse model engineered to investigate human brain-derived neurotrophic factor in vivo |
| Q28573793 | Activation of retinoic acid receptor gamma induces proliferation of immortalized hippocampal progenitor cells |
| Q42472407 | An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease. |
| Q45864059 | BDNF gene transfer to the mammalian brain using CNS-derived neural precursors |
| Q34065279 | Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease |
| Q42513244 | Brain-derived neurotrophic factor inhibits apoptosis and dopamine-induced free radical production in striatal neurons but does not prevent cell death |
| Q28140390 | Building brains: neural chimeras in the study of nervous system development and repair |
| Q28385606 | Cell delivery of therapeutic nanoparticles |
| Q34709440 | Cell-mediated drug delivery. |
| Q42437412 | Expression of catalytic trkB gene in the striatum and the basal forebrain of patients with Alzheimer's disease: an in situ hybridization study |
| Q48475009 | Focal cerebral ischemia in rats induces expression of P75 neurotrophin receptor in resistant striatal cholinergic neurons |
| Q28543023 | GDNF-transfected macrophages produce potent neuroprotective effects in Parkinson's disease mouse model |
| Q36350210 | Gene therapy: can neural stem cells deliver? |
| Q33693779 | Genetic regulatory elements introduced into neural stem and progenitor cell populations |
| Q97549564 | Genetically modified macrophages accomplish targeted gene delivery to the inflamed brain in transgenic Parkin Q311X(A) mice: importance of administration routes |
| Q45861497 | Liposome-mediated NGF gene transfection following neuronal injury: potential therapeutic applications |
| Q37517550 | Long-term functional recovery from age-induced spatial memory impairments by nerve growth factor gene transfer to the rat basal forebrain |
| Q41235622 | Neuronal progenitors as tools for cell replacement in the nervous system |
| Q35604539 | Potential use of stem cells in neuroreplacement therapies for neurodegenerative diseases. |
| Q33749480 | Promoter-activated expression of nerve growth factor for treatment of neurodegenerative diseases |
| Q41180628 | Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells |
| Q21133553 | Specific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseases |
| Q99579313 | Stem cell therapy for Alzheimer's disease |
| Q37119760 | Stem cells and neurodegenerative diseases |
| Q45882612 | Tf-lipoplex-mediated NGF gene transfer to the CNS: neuronal protection and recovery in an excitotoxic model of brain injury. |
| Q89599712 | Thalamostriatal degeneration contributes to dystonia and cholinergic interneuron dysfunction in a mouse model of Huntington's disease |
| Q74697359 | The role of neuronal growth factors in neurodegenerative disorders of the human brain |
Search more.